Liposomes encapsulating uranyl acetate or ferritin were injected intravenously into mice. At periods of 20 min, 1 h and 4 h post-injection, animals were killed, and livers were excised. Transmission electron micrographs of liver tissue showed association of oligolamellar liposomes with mitochondria for each time period. At 1 h post-injection, an average of one out of ten mitochondria was associated with liposomes. In most cases, the liposomes were clearly enclosed in a cytoplasmic vacuole. Phagocytosis by Kupffer cells as well as fusion with primary lysosomes and inclusion in secondary lysosomes was observed. No difference in intracellular fate was observed when lactosylceramide was incorporated in the liposome bilayers, suggesting that the differences observed in biochemical studies are at the level of liposome-plasma membrane interaction. When liposomes containing uranyl acetate were intravenously injected and hepatocytes were isolated by collagenase perfusion one hour later, transmission EM revealed the presence of liposomes in these cells, in cytoplasmic vacuoles in the cytoplasm and in association with mitochondria. A freeze-fracture-etching analysis of liver tissue excised 20 min after injection of liposomes encapsulating ferritin, further supported the observation that liposomes associate with mitochondria in the liver.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0005-2736(84)90288-8 | DOI Listing |
Asian Pac J Cancer Prev
January 2025
All India Institute of Medical Sciences, Department of Biochemistry, Vijaypur, Jammu, India.
Doxorubicin, a widely used anthracycline antibiotic, has been a cornerstone in cancer chemotherapy since the 1960s. In addition to doxorubicin, anthracycline chemotherapy medications include daunorubicin, idarubicin, and epirubicin. For many years, doxorubicin has been the chemotherapy drug of choice for treating a broad variety of cancers.
View Article and Find Full Text PDFJ Liposome Res
January 2025
School of Pharmacy and Food Engineering, Wuyi University, Jiangmen, Guangdong, China.
This study aimed to design a novel liposome containing GA modified phosphatidylcholine lipid (GA-PC Lip) and determine its susceptibility to tumor over-expressed secretory phospholipase A (sPLA) and its anti-cancer effect compared to conventional liposomes (Convention Lip). The liposomes were characterized for size, drug loading, encapsulation efficiency, and stability. A 6-CF release assay was conducted to assess the sensitivity of the liposomes to the tumor-overexpressed secretory phospholipase A (sPLA).
View Article and Find Full Text PDFLangmuir
January 2025
Department of Polymer and Materials Chemistry, Faculty of Chemistry & Petroleum Sciences, Shahid Beheshti University, P.O. Box 1983969411 Tehran, Iran.
Liposomes are highly beneficial nanocarrier systems due to their biocompatibility, low toxicity, and exceptional inclusiveness, which lead to improved drug bioavailability. For biological applications, accurate control over these nanoparticles' mean size and size distribution is essential. Micromixers facilitate the continuous production of liposomes, enhancing the precision of size regulation and reproducibility.
View Article and Find Full Text PDFNano Lett
January 2025
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, P. R. China.
Pancreatic ductal adenocarcinoma (PDAC) remains an aggressive malignancy. The occurrence of perineural invasion is associated with neuropathic pain and poor prognosis of PDAC, underscoring the active participation of nerves and their potential as therapeutic targets. Lidocaine is a local anesthetic with antitumor properties in some tumors in the clinic.
View Article and Find Full Text PDFJ Transl Med
January 2025
Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.
Background: Acute pancreatitis (AP) presents a significant clinical challenge with limited therapeutic options. The complex etiology and pathophysiology of AP emphasize the need for innovative treatments. This study explores mRNA-based therapies delivering fibroblast growth factor 21 (FGF21) and apolipoprotein A1 (APOA1), alone and in combination, for treating experimental AP.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!